about
The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisitedCrystal structure of a zinc-activated variant of human carbonic anhydrase I, CA I Michigan 1: evidence for a second zinc binding site involving arginine coordinationCrystal structure of a blue laccase from Lentinus tigrinus: evidences for intermediates in the molecular oxygen reductive splitting by multicopper oxidasesCatechol 1,2-dioxygenase from the Gram-positive Rhodococcus opacus 1CP: quantitative structure/activity relationship and the crystal structures of native enzyme and catechols adductsX-Ray diffraction analyses of the natural isoquinoline alkaloids Berberine and Sanguinarine complexed with double helix DNA d(CGTACG)The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1Crystal structures of salicylate 1,2-dioxygenase-substrates adducts: A step towards the comprehension of the structural basis for substrate selection in class III ring cleaving dioxygenasesReaction intermediates and redox state changes in a blue laccase from Steccherinum ochraceum observed by crystallographic high/low X-ray dose experimentsThe generation of a 1-hydroxy-2-naphthoate 1,2-dioxygenase by single point mutations of salicylate 1,2-dioxygenase--rational design of mutants and the crystal structures of the A85H and W104Y variantsX-ray crystallographic and molecular docking studies on a unique chloromuconolactone dehalogenase from Rhodococcus opacus 1CPCombining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studiesStructural basis for the substrate specificity and the absence of dehalogenation activity in 2-chloromuconate cycloisomerase from Rhodococcus opacus 1CPCrystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic StudiesSolution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexesDeterminants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD InvestigationSynthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.The [Au(9-methylcaffein-8-ylidene)2]+ / DNA Tel23 System: Solution, Computational and Biological Studies.1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads.Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.Function of different amino acid residues in the reaction mechanism of gentisate 1,2-dioxygenases deduced from the analysis of mutants of the salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans.Crystallization and preliminary X-ray crystallographic analysis of the small subunit of the heterodimeric laccase POXA3b from Pleurotus ostreatus.Crystallization and preliminary structure analysis of the blue laccase from the ligninolytic fungus Panus tigrinus.Crystallization and preliminary X-ray crystallographic analysis of hydroquinone dioxygenase from Sphingomonas sp. TTNP3.Preliminary crystallographic analysis of salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidansX-ray structures of 4-chlorocatechol 1,2-dioxygenase adducts with substituted catechols: new perspectives in the molecular basis of intradiol ring cleaving dioxygenases specificity.4-Chlorocatechol 1,2-dioxygenase from the chlorophenol-utilizing Gram-positive Rhodococcus opacus 1CP: crystallization and preliminary crystallographic analysis.Salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans: crystal structure of a peculiar ring-cleaving dioxygenase.Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)- pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their iodomethylates.Crystal structure of 4-chlorocatechol 1,2-dioxygenase from the chlorophenol-utilizing gram-positive Rhodococcus opacus 1CP.Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators.The salicylate 1,2-dioxygenase as a model for a conventional gentisate 1,2-dioxygenase: crystal structures of the G106A mutant and its adducts with gentisate and salicylate.Crystal structure of the hydroxyquinol 1,2-dioxygenase from Nocardioides simplex 3E, a key enzyme involved in polychlorinated aromatics biodegradation.Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach Investigation.The crystal structures of native hydroquinone 1,2-dioxygenase from Sphingomonas sp. TTNP3 and of substrate and inhibitor complexes.Famotidine, an Antiulcer Agent, Strongly Inhibits and Human Carbonic AnhydrasesDiscovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IXSulfonamide carbonic anhydrase inhibitors: Zinc coordination and tail effects influence inhibitory efficacy and selectivity for different isoformsDeterminants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation
P50
Q27618186-01BC26EE-826E-44AA-9DB3-445D6F8EF164Q27638978-3BB35A81-F2C0-469D-92A3-786DFB2D0BFFQ27648527-565B1062-DADD-47F6-9078-48BF53F02B5DQ27658812-025D22D4-07BF-4093-AF45-A9493A489124Q27667085-BFDE9738-D380-49E9-8EFE-09974304C583Q27674766-6F3A946C-1CB8-4E1C-AA36-5517CAD0C6A5Q27676082-0B94DE09-B2B8-4A39-979F-C13A18819668Q27677319-D9626EB6-B094-459F-ADD1-0EC028C31C47Q27682222-E7567686-3A21-48A7-9928-5F22CFCB21FFQ27683884-952784E4-9D8D-4A7A-94AB-D6536B5F0DD0Q27687793-416F7653-803F-428E-93C0-73829F80534EQ27690105-01E88FE3-E08F-4586-99A0-0115D2B9A2ABQ27702913-4E84EAED-631D-4DA9-9988-75E08F6FE252Q27703512-334001B8-02CE-4EEB-8C5D-42C4C8A62C6AQ27704001-33A0B5CA-4EE4-4111-92E8-C2B618195A51Q27704204-9B520D2C-9B6C-4836-89A1-F24ABE523DA2Q33274170-C1C2E7BE-2373-4171-BD2B-35E13B4F5F44Q38655650-EDA0A238-E811-463E-887E-83CC6984B9A0Q38669490-79DE5CA9-3843-4D19-A799-8EAB906A1F5AQ40019274-733EBBC9-6CD5-45D0-B389-D70308FCBC1EQ40817869-05153A27-AE25-4C65-BAF1-150CA69C9595Q42000256-45B3CAED-21E7-46E9-9101-FEEF4D418B8AQ42001927-03866D81-2CD1-4EB3-8BFF-8FEBEBF8797FQ42200493-C7E2B692-DDF4-4C26-BB1C-28A8ED4B5644Q42230482-8EAA6FCF-9521-47A8-A057-1B0832CBBCECQ43484663-1656E893-F945-4F81-B88B-F93001E3243BQ44010736-63BF6B52-7073-42EF-BCAD-C0E574702029Q44126518-5C74F322-717F-4C1B-9773-775C4A94CF50Q44485783-07DAC1B1-C664-46CB-A513-00C11E5B3E18Q44827069-21B4D728-8467-471C-AF65-0B1DA7D89EAEQ45238460-CD596A5E-1017-4F2C-976B-AF1CA0A9AF57Q46217217-18B1CEA8-156C-40C8-9CA0-15E7271D070EQ46384109-0BC2BED6-584C-45F4-A864-851B7804698DQ46612849-392F2A39-DE0B-4208-BE02-59BDC07E1E65Q47579609-80B83ACC-161C-4525-AA45-0672EB27167CQ51125237-AEA95B84-3805-4AEA-B069-42BE79B56156Q57822498-6CE7FD7F-1A61-4B6A-85A4-154F8D8B8787Q57909132-17C27309-5063-41F7-84B6-6F5EE9656760Q57909135-EFDB60ED-9D23-4051-8FCF-D18A1AB48D30Q57909142-CBC98A3D-ADE0-4D3C-AD05-1C25B614F188
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marta Ferraroni
@ast
Marta Ferraroni
@en
Marta Ferraroni
@es
Marta Ferraroni
@nl
Marta Ferraroni
@sl
type
label
Marta Ferraroni
@ast
Marta Ferraroni
@en
Marta Ferraroni
@es
Marta Ferraroni
@nl
Marta Ferraroni
@sl
prefLabel
Marta Ferraroni
@ast
Marta Ferraroni
@en
Marta Ferraroni
@es
Marta Ferraroni
@nl
Marta Ferraroni
@sl
P1053
P-6441-2016
P106
P1153
7004493915
P21
P31
P3829
P496
0000-0001-7258-738X